Skip to main
ARE

ARE Stock Forecast & Price Target

ARE Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 18%
Hold 64%
Sell 18%
Strong Sell 0%

Bulls say

Alexandria Real Estate is positioned to capitalize on strong long-term life science tailwinds thanks to its focus on providing space for lease to tenants in the industry. The company's strong market position in key locations and its partnerships in developing properties for the life science industry contribute to its potential for growth in the future. Their commitment to sustainability and focus on development opportunities are additional factors that could drive earnings growth.

Bears say

Alexandria Real Estate is facing a challenging outlook as the company is re-evaluating its development strategy and selling assets in an effort to reduce capex costs and earn revenue earlier than previously expected. Additionally, the soft life science real estate market and uncertainty surrounding the biotechnology sector could further weigh on the company's earnings and potentially disrupt operations. While the company has a record backlog and potential for long-term growth, macro headwinds and project delays could have a significant impact on future earnings. Given these factors, the company's stock may continue to face downward pressure, and a cautious approach is warranted when considering an investment.

ARE has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 18% recommend Buy, 64% suggest Holding, 18% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alexandria Real Estate Equities (ARE) Forecast

Analysts have given ARE a Hold based on their latest research and market trends.

According to 11 analysts, ARE has a Hold consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $53.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $53.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alexandria Real Estate Equities (ARE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.